Moderna (NASDAQ: MRNA) delivered one of the biggest earnings beats of the week on Friday, reporting third-quarter earnings of $0.38 per share against a consensus expectation of a $1.10 loss — a $1.48 per-share beat. Revenue came in at $1.31 billion, far above the $890.25 million analysts had pencilled in, and management used the strength to raise the company's full-year outlook.
For stock...
